A public policy advocate for the private equity/venture capital industry Michigan Venture Capital Association (MVCA) held its annual awards dinner this week to honor the year’s most important deals and venture capitalists.
During the dinner, the MVCA also named Jim Adox of Venture Investors as its new board chair.
Carrie Jones, executive director of the MVCA, says that 2013 was a good year for Michigan’s venture capital community. “The state has really been laying the ground work to bolster the venture community,” she says. “Michigan isn’t looked at as a flyover state anymore.”
Bobby Franklin, president and CEO of the National Venture Capital Association, was the keynote speaker. Jones says Franklin told the crowd that the MVCA dinner was the first event he’s attended outside of the East and West coasts. “That’s very telling, and it says a lot about Michigan’s role in the national venture capital community,” she adds.
The Plymouth-based Esperion Therapeutics received the MVCA’s Financing of the Year award for its June IPO, which raised approximately $70 million.
Tags: Venture Capital, Venture Capital firm, Venture Capital group, Venture Capital industry, Venture Capital investment, Venture Capital Investor, Venture Capital fund, VC Funding, VC, Private Equity/Venture Capital, Michigan Venture Capital Association, MVCA, Jim Adoxm Venture Investors, Carrie Jones, Bobby Franklin, National Venture Capital Association, MVCA Dinner, Plymouth, Esperion Therapeutics, IPO, Initial Public Offering.